BBIO – bridgebio pharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

BBIO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/12

11:07 am

bbio

BridgeBio Pharma (BBIO) had its "outperform" rating reaffirmed by Leerink Partners.

Low Report

BridgeBio Pharma (BBIO) had its "outperform" rating reaffirmed by Leerink Partners.

Report

3/10

05:04 pm

bbio

BridgeBio Pharma (BBIO) had its "overweight" rating reaffirmed by Barclays PLC.

Medium Report

BridgeBio Pharma (BBIO) had its "overweight" rating reaffirmed by Barclays PLC.

Report

3/10

02:07 pm

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

3/10

09:49 am

bbio

Rating for BBIO

High Report

Rating for BBIO

Report

3/10

09:49 am

bbio

Rating for BBIO

High Report

Rating for BBIO

Report

3/10

09:00 am

bbio

BridgeBio Pharma (BBIO) is now covered by William Blair. They set an "outperform" rating on the stock.

High Report

BridgeBio Pharma (BBIO) is now covered by William Blair. They set an "outperform" rating on the stock.

Report

3/10

09:00 am

bbio

BridgeBio Pharma (BBIO) is now covered by William Blair. They set an "outperform" rating on the stock.

High Report

BridgeBio Pharma (BBIO) is now covered by William Blair. They set an "outperform" rating on the stock.

Report

3/10

06:41 am

bbio

BridgeBio initiated with an Outperform at William Blair

High Report

BridgeBio initiated with an Outperform at William Blair

Report

3/10

06:41 am

bbio

BridgeBio initiated with an Outperform at William Blair

High Report

BridgeBio initiated with an Outperform at William Blair

Report

2/25

12:40 pm

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/25

12:40 pm

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/25

10:31 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/25

10:31 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/25

09:15 am

bbio

Rating for BBIO

Medium Report

Rating for BBIO

Report

2/13

09:55 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/13

09:55 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/13

09:39 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

2/13

09:39 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

1/28

08:19 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

1/28

08:19 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

1/28

08:00 am

bbio

BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.

Low Report

BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.

Report

1/27

04:24 pm

bbio

BridgeBio initiated with an Overweight at Barclays

Low Report

BridgeBio initiated with an Overweight at Barclays

Report

1/27

04:24 pm

bbio

BridgeBio initiated with an Overweight at Barclays

Low Report

BridgeBio initiated with an Overweight at Barclays

Report

1/20

10:48 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

1/20

10:48 am

bbio

Rating for BBIO

Low Report

Rating for BBIO

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.